Deka Bank Deutsche Girozentrale Aerie Pharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$7.02 - $13.33 $84,942 - $161,293	-12,100 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$10.46 - $14.46 $126,566 - $174,966	12,100 New	12,100 $136,000
Q4 2019 Feb 04, 2020	SELL	$17.72 - $25.1 $219,728 - $311,240	-12,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $228,284 - $347,200	-12,400 Reduced 50.0%	12,400 $252,000
Q2 2019 Aug 01, 2019	BUY	$28.97 - $48.21 $278,112 - $462,816	9,600 Added 63.16%	24,800 $720,000
Q1 2019 May 10, 2019	BUY	$36.32 - $49.25 $101,696 - $137,900	2,800 Added 22.58%	15,200 $948,000
Q4 2018 Feb 12, 2019	SELL	$33.0 - $60.04 $92,400 - $168,112	-2,800 Reduced 18.42%	12,400 $443,000
Q3 2018 Nov 09, 2018	SELL	$56.15 - $73.9 $22,460 - $29,560	-400 Reduced 2.56%	15,200 $0
Q1 2018 May 03, 2018	SELL	$51.15 - $61.0 $15,345 - $18,300	-300 Reduced 1.89%	15,600 $838,000
Q3 2017 Nov 06, 2017	BUY	$48.6 - $60.1 $772,740 - $955,590	15,900	15,900 $830,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.